Loading company…
Riskpilot
← Back to search
Sign in
Get full access
NeoCare Nordic ApS
APS
Active
CVR 43707795
Vesterbrogade 26
Wholesale of pharmaceutical and medical goods · NACE 4646
Est. 2022
7 employees
www.neocarenordic.com
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2025
DKK 914K
-29% vs 2024
EBITDA margin
-19.8%
-138% vs 2024
Equity ratio
50.9%
Financial strength
Net profit 2025
DKK -129K
-134% vs 2024
EBITDA — year on year
DKK millions
0M
-0M
-1M
-1M
-1M
0M
2024
0M
0%
2025
Key figures
Annual report 2025
Revenue
DKK 914K
-29%
EBITDA
DKK -181K
-138%
Net profit
DKK -129K
-134%
Total assets
DKK 5,6M
+434%
Equity
DKK 2,8M
+569%
Employees
7
—
Company information
Legal name
NeoCare Nordic ApS
CVR number
43707795
Legal form
Anpartsselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
14. december 2022
Share capital
DKK 50.431
Employees
7 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-05-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør.
Company purpose
Selskabets formål er at drive virksomhed med innovation og produktudvikling indenfor healthcare samt hermed beslægtet virksomhed.
Contact
Address
Vesterbrogade 26
Phone
+4561669909
Email
info@neocarenordic.com
Website
www.neocarenordic.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Wholesale of pharmaceutical and medical goods
Companies in København
All Denmark companies
Revenue
DKK millions
0M
0M
1M
1M
1M
1M
2024
1M
2025
EBITDA
DKK millions
0M
0M
1M
1M
1M
0M
2024
0M
2025
Income statement
DKK thousands
Item
2024
2025
Revenue
1.296
914
Staff expenses
-816
-1.096
EBITDA
480
-181
Depreciation & amort.
-0
-0
EBIT
480
-181
Net financials
-7
-29
Profit before tax
473
-210
Tax
90
-80
Net profit
383
-129
Balance sheet
DKK thousands
Item
2024
2025
Total assets
1.042
5.561
Equity
423
2.828
Long-term debt
0
1.977
Short-term debt
432
142
Total debt
432
2.119
Financial ratios
5-year trend
EBITDA margin
-19.8%
This company
15.8%
Market median
-225% vs market
2024
2025
Equity ratio
50.9%
This company
38.2%
Market median
+33% vs market
2024
2025
Return on equity
-4.6%
This company
18.4%
Market median
-125% vs market
2024
2025
Net profit margin
-14.2%
This company
8.1%
Market median
-275% vs market
2024
2025
Asset turnover
0.16×
This company
1.12×
Market median
-86% vs market
2024
2025
Debt / equity
0.97×
This company
0.62×
Market median
+56% vs market
2024
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2024-06-01 – 2025-05-31
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2022-12-14 – 2024-05-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (1)
KK
Kristine Kuni Buccoliero
Management
Management
2026
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
VitalDeSign Medical ApS
Company
33.33–49.99%
33.33–49.99%
2025
Ohmega Holding ApS
Company
25–33.32%
25–33.32%
2025
Andreas Glud Konradsen
Individual
20–24.99%
20–24.99%
2023
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
VitalDeSign Medical ApS
NeoCare Nordic ApS
(this company)
Board network connections
Board members of NeoCare Nordic ApS also hold positions in
0
other companies.
Person
Role here
Other companies
Kristine Kuni Buccoliero
Management
0 companies